"STORY AT-A-GLANCE
Researchers used computational analyses to evaluate the performance of 10 medications against the Omicron variant, finding that ivermectin outperformed all of them, including nirmatrelvir (Paxlovid) a new drug from Pfizer that has cost taxpayers $5.29 billion and costs $529 per course of treatment
Ivermectin lowers the viral load by inhibiting replication, reduces infection by 86% when used preventively, speeds recovery, protects against organ damage, lowers the risk of hospitalization and death and costs between $48 and $95 for a course of treatment depending on your location
Early treatment lowers your risk of long COVID, which includes physical and mental health conditions. According to cardiologist Dr. Peter McCullough, 50% of those sick enough to be hospitalized have symptoms of long COVID
Africa has a lower number of cases, severity of disease, hospitalizations and deaths than other areas of the world, which may be due to using prophylactic medications for endemic infections that have successfully treated COVID
At nearly no other time in history has there been this level of fear generated across the world as experienced thus far in 2020 and 2021.
The depth and breadth of the strategies used to stoke those fears has been overwhelming.
Emergency use authorizations for drugs that have not proven to be effective in trials,
public mask mandates for which there is no scientific evidence,
and the suppression and censorship of health information has boosted public fear over a viral illness with a survival rate of over 99%.
Unfortunately, many of the early effective treatment strategies that can be used at home have also fallen victim to censorship.
Ivermectin is one of those strategies.
In a computational analysis of the Omicron variant against several therapeutic agents, data show that ivermectin had the best results." ...
Monday, February 14, 2022
New Study Confirms Ivermectin Outperforms Other Options, by Dr. Joseph Mercola
FULL ARTICLE HERE:
